Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Catherine C. Turkel currently holds 3,100 shares of Lexaria Bioscience Corp. (LEXX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Catherine C. Turkel has been a net buyer of LEXX stock. They have purchased $284.7K and sold $18.6K worth of shares.
Catherine C. Turkel's most recent insider trade was on Aug 12, 2024, when they purchased 1,600 shares at $3.13 per share.
Catherine C. Turkel serves as Executive at Lexaria Bioscience Corp. (LEXX). They have executed 12 insider transactions totaling $303.3K over their tenure at the company.
Catherine C. Turkel holds the position of Executive at Lexaria Bioscience Corp., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Catherine C. Turkel has shown a buying trading pattern, with $284.7K in total purchases and $18.6K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Catherine C. Turkel was on May 10, 2017, when they purchased $111.0K worth of NVUS shares. This transaction involved 11,111 shares at $9.99 per share.
Catherine C. Turkel currently owns 3,100 shares of Lexaria Bioscience Corp. (LEXX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Catherine C. Turkel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Catherine C. Turkel has 12 Form 4 filings on record as an insider at Lexaria Bioscience Corp..
Set alerts for Catherine C. Turkel and 40,000+ other insiders.